Literature DB >> 24023321

Morbid obesity does not disadvantage patients with in situ or early-stage carcinoma undergoing breast-conserving surgery.

Federico Ampil1, Gloria Caldito, Benjamin Li, Srinivas Devarakonda, Gary Burton, Roger H Kim, Quyen Chu.   

Abstract

AIM: To determine whether morbidly obese (MO) patients with early-stage breast cancer (BCa) benefit from standard-of-care interventions. PATIENTS AND METHODS: Between 1992 and 2005, 100 patients underwent breast-conserving surgery and postoperative whole-breast irradiation of 50 Gy for minimally invasive BCa with tumor-free surgical margins. Twenty-seven MO women were compared to 73 non-morbidly obese (NMO) patients.
RESULTS: At 10 years, the cumulative disease-free survival rate for the NMO patients was 91% compared to the non-statistically significant lower rate of 89% in the MO women (p=0.66). Patients who were excessively obese were not at an increased risk for local (p=0.99) or regional disease recurrence (p=0.29).
CONCLUSION: The results suggest that patients with minimally invasive BCa and excessively large body habitus should not be disqualified from receiving breast-conserving therapy.

Entities:  

Keywords:  Morbid obesity; breast cancer; breast-conservation surgery; chemotherapy; radiotherapy

Mesh:

Year:  2013        PMID: 24023321

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Effect of obesity and clinical factors on pre-incision time: study of operating room workflow.

Authors:  Narges Hosseini; M Susan Hallbeck; Christopher J Jankowski; Jeanne M Huddleston; Amrit Kanwar; Kalyan S Pasupathy
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.